Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Preliminary Communication titled “Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing,”1 published in the September 5, 2017, issue of JAMA, conflict of interest disclosures were not reported accurately by José Baselga, MD, PhD. Dr Baselga has written a Letter to the journal2 explaining this inconsistent reporting of potential conflict of interest disclosures. This article was corrected online.
Missing Conflict of Interest Disclosure. JAMA. 2018;320(22):2381. doi:10.1001/jama.2018.17511
Coronavirus Resource Center
Create a personal account or sign in to: